Australian patients report lasting benefits—and access barriers
Long-term experiences of patients prescribed medicinal cannabis in Australia: a qualitative interview study.
AI Summary
This qualitative study explored the long-term experiences of 15 Australian patients prescribed orally administered medicinal cannabis oil for chronic pain, insomnia, muscle spasticity, anxiety, or depression. Participants often sought cannabis after finding conventional treatments unsatisfactory and commonly used it to reduce or replace other medications. They viewed it as a relatively low-risk, “natural” option, although these were personal perceptions rather than measures of clinical effectiveness.
Participants described improvements in symptoms that they felt benefited their relationships, productivity, and mental health. They also reported managing side effects themselves, with perceived benefits outweighing those concerns. However, access remained difficult because of prescription hurdles and product costs, while roadside drug testing was an ongoing worry. The authors conclude that simpler prescribing, better education, and less prohibitive driving laws could improve patient-centred care and acceptance of medicinal cannabis in Australia.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More Pain research papers you might find interesting.
Interviews explore how adults with regular pain perceive cannabis use
An 18-month cohort found adverse outcomes were infrequent, but long-term risks…
Language models can extract documented cannabis use, but need validation
Explore More Research
Stay informed about the latest cannabis science.